key: cord-0760790-h01v3k6g authors: Saffarian, Zahra; Samii, Rana; Ghanadan, Alireza; Vahidnezhad, Hassan title: De novo severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BBIBP‐CorV date: 2022-03-20 journal: Dermatol Ther DOI: 10.1111/dth.15448 sha: bbf09679069a27ae7f02a0c1c20b9fd93ce00241 doc_id: 760790 cord_uid: h01v3k6g nan 1, the components of intraepithelial desmosomes, lead to acantholysis causing blisters and erosions. 1 Pemphigus Nat Rev Dis Primers The genetics of pemphigus vulgaris Skin manifestations in COVID-19 patients: are they indicators for disease severity? A systematic review Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2 Development of pemphigus vulgaris after the second dose of the mRNA-1273 SARS-Cov-2 vaccine Oral pemphigus after COVID-19 vaccination COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide Cutaneous findings following COVID-19 vaccination: review of world literature and own experience Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases